scorecardresearch
Saturday, May 4, 2024
TopicHydroxychloroquine

Topic: hydroxychloroquine

WHO to resume HCQ trial for Covid it had paused after controversial Lancet article

The World Health Organization will resume recruiting Covid patients for the hydroxychloroquine arm of a global trial called Solidarity.

Lancet HCQ study row: Did WHO, experts rush to damn the drug due to Trump, Modi politics?

Medical journal The Lancet has admitted that questions have been raised about the data published in its earlier paper on hydroxychloroquine drug.

Modi govt to study WHO decision to halt HCQ trial, expert panel to review dosage

The suspension of WHO’s hydroxychloroquine clinical trial was to be taken up by an expert committee last week, but the discussions were eventually ‘deferred’.

How Trump, Modi and a low price tag made 80-year-old HCQ a political hot potato

In episode 484 of #CutTheClutter, Shekhar Gupta explains how HCQ, touted as a promising preventive and treatment for Covid-19, became politicised.

Why researchers are questioning Lancet study that linked HCQ to higher Covid death risk

More than a hundred scientists have raised questions about the dataset used in the study published by The Lancet, which led to WHO halting all trials of HCQ.

Everyone is cherrypicking studies on HCQ. But scientists are divided

Unlike what media reports suggest, there is no evidence one way of the other that you can prevent Covid-19 by taking hydroxychloroquine.

We analysed HCQ risks and benefits, will continue to recommend for prevention: ICMR chief

ICMR DG Balram Bhargava’s statement comes amid rising concern on hydroxychloroquine increasing mortality rate when used as a treatment in Covid-19 patients.

Hydroxychloroquine-azithromycin combo may adversely affect cardiovascular system: US study

Researchers carried out an observational, retrospective meta-analysis of a WHO database encompassing over 21 million adverse event case reports.

ICMR & Lancet HCQ study aren’t at odds. One is on preventing Covid, other about treating it

A Lancet study Friday said HCQ raises chances of death and irregular heart rhythm. On the same day, ICMR advised expansion of HCQ usage as prevention drug.

HCQ has ‘tremendous, rave reviews’, Trump says after finishing a course of treatment

Trump, who at 73 is in an age group at which contracting Covid-19 can be especially dangerous, began HCQ treatments in consultation with White House physicians.

On Camera

Stop targeting Galgotias University students. Focus on politicians instead

Going through their Instagrams and dissecting their ‘statements’ is not the astute political commentary you think it is—it is time for us to back off from targeting 20-year-olds.

High capacity usage, fresh borrowings & new orders — why FY25 could be a big year for pvt investment

Companies are borrowing more from banks and public. Economists say high capacity utilisation & growing new orders could set stage for renewed investment push by India Inc.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.